KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Shares Repurchased (2016 - 2025)

Quest Diagnostics' Shares Repurchased history spans 17 years, with the latest figure at $300.0 million for Q4 2025.

  • For Q4 2025, Shares Repurchased rose 98.68% year-over-year to $300.0 million; the TTM value through Dec 2025 reached $726.0 million, up 70.42%, while the annual FY2025 figure was $450.0 million, 198.01% up from the prior year.
  • Shares Repurchased for Q4 2025 was $300.0 million at Quest Diagnostics, up from $151.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $1.5 billion in Q2 2021 and bottomed at $151.0 million in Q4 2024.
  • The 5-year median for Shares Repurchased is $336.5 million (2022), against an average of $433.3 million.
  • The largest annual shift saw Shares Repurchased skyrocketed 446.67% in 2021 before it plummeted 86.67% in 2022.
  • A 5-year view of Shares Repurchased shows it stood at $289.0 million in 2021, then skyrocketed by 59.52% to $461.0 million in 2022, then crashed by 40.35% to $275.0 million in 2023, then tumbled by 45.09% to $151.0 million in 2024, then surged by 98.68% to $300.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Shares Repurchased are $300.0 million (Q4 2025), $151.0 million (Q4 2024), and $275.0 million (Q4 2023).